416 results on '"Egan, Sean E"'
Search Results
2. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer
3. Subtype-specific role for Jagged1 in promoting or inhibiting breast tumor formation.
4. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
5. ITSN
6. Out on the Fringe: Modulation of Notch Signaling by Glycosylation
7. Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast
8. Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
9. The tumor cell‐derived matrix of lobular breast cancer: a new vulnerability
10. Spatial gene expression analysis of neuroanatomical differences in mouse models
11. Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay
12. Supplementary Data from Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
13. Data from Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
14. Notch Signaling in Lung Development and Disease
15. Supplementary Table 1 from Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients
16. Supplementary Figures 1-5 from Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients
17. Supplementary Figure Legends from Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients
18. Supplementary Figure 4 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
19. Supplementary Table 4A from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
20. Supplementary Tables 1-3 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
21. Supplementary Table S2 from High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival
22. Data from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
23. Supplementary Figure 5 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
24. Supplementary Table 2 from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
25. Supplementary Figure 6 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
26. Data from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
27. Supplementary Figure 2 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
28. Supplementary Figure Legends from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
29. Supplementary Figure 2 from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
30. Supplementary Figure 9 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
31. Supplementary Figure 4 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
32. Supplementary Table 2B from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
33. Supplementary Figure 7 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
34. Supplementary Figure Legends from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
35. Supplementary Table 1 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
36. Supplementary Figure 1 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
37. Supplementary Figure 4 from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
38. Supplementary Figure 7 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
39. Supplementary Figure 3 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
40. Supplementary Figure 2 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
41. Supplementary Figure 5 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
42. Supplementary Figure 3 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
43. Supplementary Table 3 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
44. Supplementary Figure 1 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
45. Supplementary Information from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
46. Supplementary Figure 6 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
47. Supplementary Table 1 from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
48. Supplementary Figure 3 from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
49. Supplementary Figure 1 from Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
50. Supplementary Figure 8 from Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.